The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Victrelis™ (boceprevir) and Hepatitis C

What is the dosage for Victrelis™ (boceprevir)?

UPDATE: As of January 2015 Merck announced it will discontinue selling Victrelis in the United States by the end of the year.

According to Merck, developer of Victrelis™, the dosage and administration of the medication will differ for various groups.

Keep in mind that Victrelis™ MUST be taken in combination with peginterferon alfa and ribavirin. In general, the dosage would be four 200 mg capsules three times daily (approximately every 7-9 hours) with food.

Last Updated: January 2015

Merck "Highlights of Prescribing Information - Victrelis" http://www.merck.com/product/usa/pi_circulars/v/victrelis/victrelis_pi.pdf. Retrieved May 18, 2011.

Merck "Medication Guide - Victrelis™" http://www.merck.com/product/usa/pi_circulars/v/victrelis/victrelis_mg.pdf. Retrieved May 18, 2011.

Merck "Patient Assistance Programs" http://www.merck.com/responsibility/pap-information.html. Retrieved May 23, 2011.

Neutropenia Support Association, Inc. "What is Neutropenia?" http://www.neutropenia.ca/. Retrieved May 19, 2011.

Victrelis http://victrelis.com/boceprevir/victrelis/consumer/index.jsp. Retrieved May 23, 2011.